Navigation Links
Syngenta Issues EUR 500 Million Eurobond

BASEL, Switzerland, June 23 /PRNewswire-FirstCall/ -- Syngenta announced today the successful issue of a EUR 500 million Eurobond with a five year maturity. The proceeds of the bond will be used for general funding purposes.

John Ramsay, CFO, said: "We have taken advantage of favorable current borrowing conditions in order to further enhance our debt maturity profile. This bond issue is part of our normal funding requirements and the positive market reception demonstrates Syngenta's strong financial position and credit quality."

Syngenta (NYSE: SYT) is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to or

    Syngenta International AG

    Media Office
    CH-4002 Basel
    Tel:        +41 61 323 23 23
    Fax:        +41 61 323 24 24

    Media contact:

    Medard Schoenmaeckers
    Switzerland   +41 61 323 2323

    Analyst/Investor contacts:

    Jennifer Gough
    Switzerland   +41 61 323 5059
    USA           +1 202 737 6521

    John Hudson
    Switzerland   +41 61 323 6793
    USA           +1 202 737 6520

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

SOURCE Syngenta
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta Licenses Chromatin Gene Stacking Technology
2. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
3. Syngenta To Build Major Global Biotech Research Center in Beijing, China
4. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
5. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
6. Syngenta Enters Into Research Collaboration With Anhui Academy, China
7. Syngenta Board Proposes Stefan Borgas to Become New Director
8. Syngenta holds Annual General Meeting
9. Syngenta Acquires Innovative Bio-Control Technology to Improve Usable Crop Yields
10. Pharmos Issues Letter to Shareholders
11. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
Post Your Comments:
(Date:12/1/2015)...  CardioCell LLC, a Stemedica Cell Technologies Inc. ... indications, intends to proceed with finalizing a Phase ... a Heart Failure Advisory Board comprising cardiology key ... members . In a recent meeting members of ... efficacy data from CardioCell,s on-going chronic heart failure ...
(Date:12/1/2015)... Frederick, MD (PRWEB) , ... December 01, 2015 ... ... management solutions provider, announces that its best selling system laboratory animal colony management ... ezColony® Cloud today, without investing in on-site IT resources., , ...
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  Symic, ... and affect the extracellular matrix (ECM), today announced that ... financing to advance the company,s pipeline, including its lead ... Lilly Ventures and includes the participation by all existing ... new funding brings the total capital raised by Symic ...
(Date:12/1/2015)... , December 1, 2015 Dr. Harry Lander , President ... serving as Chief Science Officer and recruits five ... Harry Lander , President of Regen, expands his role to ... recruits five distinguished scientists to join advisory team ... expands his role to include serving as ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):